IFNG and COVID-19: These findings indicate that assays heavily relying on assessment of IFN-γ production, such as IFN-γ ELISPOT analysis (19), most likely underestimate the magnitude of SARS-CoV-2–specific T cell response in the context of COVID-19 vaccination.